🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor

Recruitingn/aAges 18 Years - anyAllFondazione Policlinico Universitario Agostino Gem…
NCT06076005 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age \>18 years * Suspicion of lung cancer based on imaging (CT and/or PET/CT) * Indication to a biopsy for diagnosis, staging and/or molecular profiling Exclusion Criteria: * Inability or unwillingness to provide a written informed consent * ECOG performance status (\>3) which makes a tissue diagnosis unfeasible * ASA 4 status * TNM Stage I-III
💊

What it tests

  • Advanced lung cancer patients' group
📍

Where

3 sites
Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy
Istituto Nazionale Tumori Regina Elena
Roma, Italy
Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy